ENOV Enovis Corp

Wilmington, DE, Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- Enovis™ Corporation ( NYSE: ENOV ) , an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global Healthcare Conference at 2:35 p.m. ET on Wednesday, September 10th, 2025.

The consensus price target hints at a 69.9% upside potential for Enovis (ENOV). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 77.3% in Enovis (ENOV). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wilmington, DE, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Enovis™ Corporation ( NYSE: ENOV ) , an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: ...

Wilmington, DE, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Enovis™ Corporation ENOV, an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Canaccord Genuity 45th Annual Growth Conference on Wednesday, ...

Enovis ( NYSE:ENOV ) , a medical technology company focused on orthopedics and recovery products, announced results for Q2 2025 on August 7, 2025. The headline news was a clear beat on both GAAP revenue and non-GAAP adjusted earnings per share.